PVCT
PVCT clinical trials: PROVECTUS BIOPHARMACEUTICALS, INC.
Every trial on ClinicalTrials.gov where PROVECTUS BIOPHARMACEUTICALS, INC. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 14
- Trials linked
- 13
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
PVCT on the catalyst calendar · PVCT registry changes
- Primary completion May 2023ActualPhase 1/Phase 2NCT02557321PV-10 in Combination With Pembrolizumab for Treatment of Metastatic MelanomaProvectus Biopharmaceuticals, Inc. · MelanomaUnknown statusPVCTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 1, 2021ActualPhase 1NCT02693067A Phase 1 Study of PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the LiverProvectus Biopharmaceuticals, Inc. · Neuroendocrine Tumors Metastatic to the LiverUnknown statusPVCTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2022Sponsor estimatePhase 1NCT00986661A Study to Assess PV-10 Chemoablation of Cancer of the LiverProvectus Biopharmaceuticals, Inc. · Cancer Metastatic to the LiverUnknown statusPVCTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2019ActualPhase 3NCT02288897PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous MelanomaProvectus Biopharmaceuticals, Inc. · Cutaneous MelanomaTerminatedPVCTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2008ActualPhase 2NCT00555646Topical PH-10 Aqueous Hydrogel and Photodynamic Therapy for PsoriasisProvectus Pharmaceuticals · Plaque PsoriasisTerminatedPVCTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2015ActualPhase 2NCT02322086A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10Provectus Pharmaceuticals · PsoriasisCompletedPVCTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredNo phase registeredNCT01260779Expanded Access Protocol for PV-10 for Cutaneous or Subcutaneous TumorsProvectus Biopharmaceuticals, Inc. · Cutaneous or Subcutaneous Tumors Where There is no Comparable or SatisfactoryNo longer availablePVCTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2010ActualPhase 2NCT00521053Phase 2 Study of Intralesional PV-10 for Metastatic MelanomaProvectus Pharmaceuticals · MelanomaCompletedPVCTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2011ActualPhase 2NCT01247818Randomized Study of PH-10 for PsoriasisProvectus Pharmaceuticals · PsoriasisCompletedPVCTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2009ActualPhase 2NCT00941278An Efficacy and Safety Study of PH-10 Aqueous Hydrogel for the Treatment of Plaque PsoriasisProvectus Pharmaceuticals · PsoriasisCompletedPVCTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2009ActualPhase 2NCT00690807A Phase 2 Study of PH-10 for the Treatment of Atopic DermatitisProvectus Pharmaceuticals · Atopic DermatitisCompletedPVCTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2008ActualPhase 1NCT00237354PV-10 Chemoablation of Recurrent Breast CarcinomaProvectus Pharmaceuticals · Breast CancerCompletedPVCTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 1NCT00219843Intralesional PV-10 Chemoablation of Metastatic MelanomaProvectus Pharmaceuticals · MelanomaCompletedPVCTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 29, 2015ActualPhase 1NCT01760499Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility StudyH. Lee Moffitt Cancer Center and Research Institute · MelanomaCompletedPVCTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 14 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner